We’re thrilled to share that we’ve received FDA 510(k) clearance for Ibex Prostate Detect! This clearance affirms our commitment to the safety and efficacy of our AI platform and to providing solutions that improve patient health outcomes.

RT @UrologyTimes: The #FDA has granted 510(k) clearance to Ibex Prostate Detect, an AI-powered digital pathology tool designed to detect pr…

Ibex’s 2024 Patient Insight Report on Cancer Diagnostics reveals 62% of people fear #cancer diagnosis & 89% report a need for better technology to help diagnose cancer. We must embrace #AI in diagnostics now – it’s the present, not the future:

#WorldCancerDay is a time to reflect on the million of lives impacted by cancer every day. Ibex is dedicated to increasing awareness, supporting healthcare providers & we're honored to be a part of a community working to advance patient care through improved cancer diagnostics.

Prostate cancer has become the most common cancer in England w/ 55,000+ cases annually, reports @guardian. Awareness and screening rates have increased thanks to @ProstateUK & @NHSEngland, and accurate & timely diagnostics are more important than ever.

Ibex’s Manuela Vecsler is featured in a recent @TargetedOnc article! This article discusses the significance of determining the HER2 status as targeted therapies increasingly differentiate treatment effectiveness based on HER2 status. Read here:

RT @SBRICOE: 🚨 Exciting update! 🚨 We're thrilled to announce the 5 companies we are working with as part of the SBRI Cancer Challenge in co…

RT @WGHealthandCare: 5 innovative projects have won funding to improve outcomes for cancer patients. 🧑‍⚕️ Thanks to collaboration between…

We're honored to support the NHS Wales team in providing timely and accurate cancer diagnostics. Learn more here:

Through an #AI in Health and Care Award, Ibex is currently supporting #breastcancer diagnosis across 4 @NHSEngland Trusts & @BetsiCadwaladr. We're committed to supporting the @NHS & collaborating w/ UK patients to best serve their needs. Learn more here:

We'll be in Manchester Feb 6th for @Convenzis_Group's NHS North Pathology Conference. Stop by our booth for a live demo of Ibex's Platform, the most widely deployed #AI in #pathology & trusted by pathologists around the world. Schedule time with our team:

Global leaders in #digitalpathology and #AI adoption, @CorePlusPR published their 3+ years of real-world experience using Ibex's #AI for #prostatecancer diagnosis. Data showed NPV of 99.2% & solution normalized pathologist performance. #pathology

One of our favorite 2024 memories was introducing new annual customer awards to recognize labs using Ibex #AI in routine care to bring patients the highest quality #cancerdiagnostics. Looking forward to more accomplishments together in 2025! Learn more:

We take pride in developing strong, lasting relationships & we're thrilled to see such high levels of satisfaction reported among our customers! Review this @KLASresearch Report for direct feedback from customers using our #AI-powered tools:

"AI is already being used in UK hospitals for important tasks such as diagnosing cancer more quickly and it will continue to be used to support the NHS." Honored to support our UK customers & excited to see the govt's commitment to further investing @BBC

To meet increasing demand & #pathology case complexity, @ZAS_Ziekenhuis adopted & integrated Ibex’s #AI platform within their Laboratory Information System, creating fully automated AI-powered workflows for improved accuracy and efficiency. Learn more:

The Ibex team will be at #JPM2025 next week in San Francisco! Schedule time to learn how Ibex is transforming cancer diagnostics with #AI-powered tools for pathologists: #digitalpathology #healthcareAI #cancerdiagnostics #precisionmedicine

Learn about Ibex Breast here: